Aster Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Aster Capital Management's BMY Position: Q2 2026 in Review
Aster Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 9,310 shares worth $536K. The stake represents 0.11% of the portfolio and ranks #251 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in BMY as recently as Q4 2025.
Aster Capital Management first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. The position peaked at $1M in Q4 2025. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Aster Capital Management held 9,310 shares of Bristol-Myers Squibb worth $536K as of Q2 2026.
- Bristol-Myers Squibb was a new Aster Capital Management position in Q2 2026.
- Bristol-Myers Squibb made up 0.11% of Aster Capital Management's portfolio in Q2 2026, its #251 holding.
- Aster Capital Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
- Aster Capital Management's Bristol-Myers Squibb position peaked at $1M in Q4 2025.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.